Read, T., Webber, S., Thomas, J., Wagels, M., Schaider, H., Soyer, H. P., & Smithers, B. M. (2017). Protocol for the TIDAL Melanoma Study: Topical imiquimod or diphenylcyclopropenone for the management of cutaneous in-transit melanoma metastases—a phase II, single centre, randomised, pilot study. BMJ Open.
Chicago Style CitationRead, Tavis, Scott Webber, Janine Thomas, Michael Wagels, Helmut Schaider, H Peter Soyer, i B Mark Smithers. "Protocol for the TIDAL Melanoma Study: Topical Imiquimod or Diphenylcyclopropenone for the Management of Cutaneous In-transit Melanoma Metastases—a Phase II, Single Centre, Randomised, Pilot Study." BMJ Open 2017.
Cita MLARead, Tavis, et al. "Protocol for the TIDAL Melanoma Study: Topical Imiquimod or Diphenylcyclopropenone for the Management of Cutaneous In-transit Melanoma Metastases—a Phase II, Single Centre, Randomised, Pilot Study." BMJ Open 2017.